Democratic lawmakers in Oregon are considering ending the state's Medicaid expansion in an effort to address a $1.6 billion budget shortfall.
In a letter to the CMS, Donald Fisher, president and CEO of the AMGA, formerly known as the American Medical Group Association, says a lack of information will prohibit participation.
Maternal care has the makings of the next frontier for bundled payments—except there's no national regulatory vehicle to help the industry get there.
The Drug Enforcement Administration believes a Utah physician may have ties to an international drug cartel, and it wants access to the state's prescription drug monitoring program to continue its investigation.
Early last month, U.S. Reps. Diane Black (R-Tenn.) and Earl Blumenauer (D-Ore.)—both of whom sit on the House Ways and Means Committee's Health Subcommittee—introduced a bill that would change how the federal tax code treats high-deductible health plans that are paired with tax-exempt...
Colorado's legalization of cannabis for recreational use is associated with an increase in the number of young children who were treated for unintentional exposure to the drug, according to a study in JAMA Pediatrics.
Physicians are increasingly selling their practices to larger groups to gain access to the capital and expertise needed to survive under value-based reimbursement.
Oregon Health & Science University has agreed to pay $2.7 million and work through a three-year corrective action plan after a federal investigation found “widespread and diverse problems” with its data protection.
Providence Health & Services in Oregon is notifying about 5,400 current and former patients that a former employee may have improperly accessed their patient records.
We asked readers to select up to three out of 25 topics covered in the Best Practices feature since it was launched in 2013. The top 10 vote-getters include using scribes to aid physicians, payers publishing the cost of services and ways to smooth the discharge process.
The development-stage biotechnology company is working on JCAR015 as a treatment for a type of leukemia. It is the company's most advanced drug candidate and therefore the most visible indicator of progress for investors.
Darcy Burthay has been promoted to president and CEO of Providence Health System in Washington, D.C., an Ascension Health subsidiary.